1. Home
  2. PTCT vs FBP Comparison

PTCT vs FBP Comparison

Compare PTCT & FBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$66.42

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Logo First BanCorp. New

FBP

First BanCorp. New

HOLD

Current Price

$20.82

Market Cap

3.6B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTCT
FBP
Founded
1998
1948
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
3.6B
IPO Year
2006
2010

Fundamental Metrics

Financial Performance
Metric
PTCT
FBP
Price
$66.42
$20.82
Analyst Decision
Buy
Buy
Analyst Count
16
4
Target Price
$80.94
$24.13
AVG Volume (30 Days)
1.0M
1.4M
Earning Date
05-05-2026
04-22-2026
Dividend Yield
N/A
3.89%
EPS Growth
264.48
18.78
EPS
7.78
2.15
Revenue
$264,734,000.00
$1,255,034,000.00
Revenue This Year
N/A
$15.10
Revenue Next Year
$19.30
$4.56
P/E Ratio
$8.40
$9.56
Revenue Growth
36.19
2.38
52 Week Low
$35.95
$16.40
52 Week High
$87.50
$23.43

Technical Indicators

Market Signals
Indicator
PTCT
FBP
Relative Strength Index (RSI) 46.70 46.37
Support Level $61.43 $20.41
Resistance Level $69.29 $22.28
Average True Range (ATR) 2.50 0.52
MACD 0.39 0.02
Stochastic Oscillator 53.71 65.80

Price Performance

Historical Comparison
PTCT
FBP

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

About FBP First BanCorp. New

First BanCorp is a financial holding company. The company's operating segment includes Commercial and Corporate Banking; Mortgage Banking; Consumer (Retail) Banking; Treasury and Investments; United States Operations; and Virgin Islands Operations. It generates maximum revenue from the Consumer (Retail) Banking segment. The Consumer (Retail) Banking segment generates majority revenue, which consists of the Corporation's consumer lending and deposit-taking activities conducted mainly through its branch network and loan centres. Geographically, it derives a majority of revenue from Puerto Rico.

Share on Social Networks: